Topics

Latest "The Hillman Company & Hillman Family Foundations" News Stories - Page: 3

22:36 EST 19th November 2019 | BioPortfolio

Here are the most relevant search results for "The Hillman Company & Hillman Family Foundations" found in our extensive news archives from over 250 global news sources.

More Information about The Hillman Company & Hillman Family Foundations on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The Hillman Company & Hillman Family Foundations for you to read. Along with our medical data and news we also list The Hillman Company & Hillman Family Foundations Clinical Trials, which are updated daily. BioPortfolio also has a large database of The Hillman Company & Hillman Family Foundations Companies for you to search.

Showing "Hillman Company Hillman Family Foundations" News Articles 51–75 of 12,000+

Monday 18th November 2019

Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data

Amidst rumors that Novartis might be interested in an acquisition, The Medicines Company announced data from ORION-10, the second of three 19-month Phase III trials of inclisiran for lowering cholesterol.


'A Clever Bit of Chemistry': NuCana CEO Speaks on Company's Biliary Tract Cancer Drug

If successful, the CEO told BioSpace in an exclusive interview that Acelarin will break the glass ceiling as the first FDA-approved treatment for biliary tract cancer.

Athenex Announces Key Company Activities at San Antonio Breast Cancer Symposium

Abstract selected for the SABCS press programOral presentation of Oral Paclitaxel and encequidar Phase III results on December 13Company to host a Key Opinion Leader webcast event for the investment community BUFFALO, N.Y., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of n...


Avante Health Solutions Announces Recent Management Changes

Sterling Peloso, President of Avante Ultrasound, has assumed operating responsibilities of Avante Patient Monitoring. CHICAGO (PRWEB) November 18, 2019 Avante Health Solutions (“Avante”) is pleased to announce that Mr. Sterling Peloso, President of Avante Ultrasound, has assumed the operating responsibilities of Avante Patient Monitoring. This expanded role will be in addition to his current ...

Western Dental and the SoCal Chapter of the NFL Alumni Provide Free Turkey Dinners

Western Dental & Orthodontics, one of the nation’s leaders in accessible, affordable oral healthcare and the leading orthodontics provider in the country, has joined with the Southern California NFL Alumni and Zoe Christian Fellowship in their annual Turkey Giveaway. Under the partnership, Western Dental will provide volunteers and food donations for 300 families in need in the Southern C...

Online Pharmacy eDrugstore Joins Inc 5000

Veteran online drugstore joins Inc 5000 with corporate parent Secure Medical Tempe, Arizona-based Secure Medical, parent company of eDrugstore.com, joined the Inc 5000 in August, after experiencing 62% revenue growth from 2015 to 2018. The Inc 5000 is for U.S.-based, privately held, independent, for-profit businesses that have shown impressive revenue growth. The growth of Secure Medical and i...

TissueTech Announces Appointment of New Chief Commercial Officer - Thomas (Tom) Williamson tapped to provide strategic oversight of sales and marketing as the company continues to expand its commercialization efforts

Miami, Fla. – November 18, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced this week the appointment of Tom Williamson to the position of Chief Commercial Officer (CCO) to support the continued strategic expansion of its mar...

Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent

Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent   Reporter: Aviva Lev-Ari, PhD, RN Next stop, filing for approval. The Medicines Company has said it plans to submit inclisiran for FDA review by the end of 2019 and EMA review in the first quarter of 2020. If the drug’s approved it’ll be […]

Researchers Present New Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2019 Chemical and Biological Defense Science & Technology Conference

New data demonstrate durable protective response for Appili’s vaccine candidate against Francisella tularensis, a Category A pathogen and potential biological weapons threat Presentation provides additional safety and efficacy data supporting use of ATI-1701 as a medical countermeasure, supports ongoing development under U.S. Food and Drug Administration’s medical countermeasure development...

Intellipharmaceutics International Inc.: Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing with Drs. Isa and Amina Odidi

TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and Drs. Isa and Amina Odidi announce tha...

TFF Pharmaceuticals to Ring NASDAQ Stock Market Opening Bell on Wednesday, November 20, 2019

The clinical-stage biopharma company celebrates its successful $22 million IPO TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, an

FDA Grants Orphan Drug Designation to Axovant Gene Therapies’ Investigational Treatment for GM1 Gangliosidosis

NEW YORK and BASEL, Switzerland, Nov. 18, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company’s investigational gene therapy, AXO-AAV-GM1, for the treatment of GM1 gangliosidosis. GM1 gangliosidos...

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Findings Released Today in Nature Biotechnology Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems. The study, entitled “Harnessing Type I CRISPR-Cas Systems for Genome Engineering in Human Cells,” was published today in the peer-reviewed scientific journal Nature B...

Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing with Drs. Isa and Amina Odidi

TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and Drs. Isa and Amina Odidi announce that, following the close of markets on November 15, 2019, the Company issued to Drs. Isa and Amina Odidi, by way of private placement, an unsecured convertible debenture of the Company ...

Older adults and wearable activity trackers

For older adults, wearable activity trackers may be popular gifts, but they may not be used for very long. While counterintuitive, engaging in competition with family and friends decreases the odds of long-term use among older adults, perhaps because they feel it's demotivating, according to a new study.

NowRx Partners with Parata Systems to Significantly Streamline Pharmacist Verification, Increase Accuracy

On-demand, free delivery pharmacy integrates revolutionary pharmacy automation and image capture technology; industry-first process increases verification efficiency, accuracy and delivery speed of prescription medications MOUNTAIN VIEW, Calif. and DURHAM, N.C. (PRWEB) November 18, 2019 NowRx, the same-day, free-delivery pharmacy, and Parata, a leader in automated dispensing with high speed and a...

ARS Treatment Centers Continues to Expand in Virginia With New Office-Based Opioid Treatment Facility in Winchester

National leader advances its commitment to provide needed resources to strengthen Virginia communities ARS Treatment Centers, a category leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Winchester, VA. The new facility is a part of the company’s new network of local clinics that provide critical treatment resources to combat the opioid crisis a...

Rapidly Growing - Spero Health Opens Cookeville Clinic to Address Drug Epidemic

Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, has announced the opening of a new clinic in Cookeville, Tennessee. The Cookeville Spero Health Clinic located at 225 N Willow Ave. will open on Friday, November 22nd and will begin seeing patients that day. For more information or to schedule an immediate appointment, individuals are encouraged to call the...

Biotest AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Biotest AG 18.11.2019 / 15:13 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Biotest AG Street: Landsteinerstraße 5 Postal code: 63303 City: DreieichGermany Legal Entity Iden...

Cannabis Stock News: Sunniva (CSE: SNN) (OTCQB: SNNVF) Announces Resignation Of President

VANCOUVER, B.C. - November 18, 2019 (Investorideas.com Newswire) Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces that for personal reasons, Kevin Wilkerson has resigned from his position of President of the Company and from the position of President and Chief Executive Officer of Sun CA Hol...

The Pathfinder Network Launches Enhanced Visiting Pilot Program for Incarcerated Parents in Oregon

Parenting Inside Out Phase II Provides Opportunity to Strengthen Connections Between Incarcerated Parents and Their Children PORTLAND, Ore. (PRWEB) November 18, 2019 After a year of development, this month The Pathfinder Network (TPN) began piloting its new parenting program, Parenting Inside Out (PIO) Phase II: Enhanced Visiting. An advanced skills development and parent-child visiting program f...

Cannabis Stock News: Curaleaf (CSE: CURA) (OTCQX: CURLF) Opens Jensen Beach's First Medical Cannabis Center

JENSEN BEACH, Fla. - November 18, 2019 (Investorideas.com Newswire) Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, opened its 27th dispensary in Florida at 3631 NW Federal Highway in Jensen Beach on Friday, November 15th.

Boston Properties Leads the Market in Rapid Adoption of Fitwel® Certification for 2019

Over the last 12 months, BXP has achieved certification of 11 projects totaling 11 million sq ft in response to market demand for healthy buildings The Center for Active Design (CfAD), operator of the Fitwel Certification System, announces today that Boston Properties (NYSE:BXP) has achieved Fitwel certification of 11 projects in 2019—exhibiting the fastest uptake of any company to date. As th...

Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Launches Kuida Brand in the US, Begins First Sales

TORONTO - November 18, 2019 (Investorideas.com Newswire) Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced the official launch of the Company's Kuida brand in the United States.

International Cannabrands Inc.: International Cannabrands Announces New Appointment to Management Team

LOS ANGELES, CA / ACCESSWIRE / November 18, 2019 / International Cannabrands Inc. (CSE:INCB) (the "Company") is pleased to announce the appointment of Greg Davis as Chief Growth Officer & Head of C...


Quick Search

News Quicklinks